ArticleActas espanolas de psiquiatria2025
Anxiety and Depression Status of Patients With Coronary Atherosclerotic Heart Disease and Its Influencing Factors.
Article in Actas espanolas de psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary atherosclerotic heart disease (CAHD) is a major global health burden with high morbidity and mortality. Psychological comorbidities, particularly anxiety and depression, are highly prevalent in CAHD patients and significantly impact disease prognosis, quality of life, and treatment adherence. This study aimed to explore the occurrence and influencing factors of anxiety and depression in patients with CAHD.
methodsA retrospective study design was used to collect clinical data and questionnaire results from 152 patients with CAHD who attended our hospital from January 2022 to January 2025. The Hamilton Anxiety scale, Hamilton Depression scale, Acceptance of Illness Scale and Social Support Rating Scale were used to assess the results, and statistical analyses were performed using SPSS (version 26.0) software, which included independent sample t-tests, chi-square tests and univariate and multiple logistic regression analysis.
resultsAmongst 152 patients with CAHD, the detection rate of anxiety symptoms was 42.76% (65 cases), and the detection rate of depressive symptoms was 46.05% (70 cases). Multiple logistic regression analysis showed that the number of coronary artery lesion branches (odds ratio (OR) = 3.15, 95% CI: 1.25-7.96, p = 0.015), the amount of long-term medication (OR = 3.26, 95% CI: 1.42-7.50, p = 0.005), and disease acceptance (OR = 0.81, 95% CI: 0.73-0.90, p < 0.001) and social support (OR = 0.88, 95% CI: 0.83-0.94, p < 0.001) were independent influencing factors of anxiety. Disease course (OR = 2.52, 95% CI: 1.18-5.41, p = 0.017), disease acceptance (OR = 0.92, 95% CI: 0.86-0.99, p = 0.047) and social support (OR = 0.95, 95% CI: 0.91-0.99, p = 0.047) were independent influencing factors of depression.
conclusionDisease acceptance and social support are the main influencing factors. Therefore, routine screening for anxiety and depression, coupled with tailored interventions, is recommended for patients with CAHD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.